MolNFT v1 · #113965 · protein
Crystal structure of cypovirus polyhedra R13K mutant
5AXV · Polyhedrin: “Crystal structure of cypovirus polyhedra R13K mutant”. X-ray diffraction, 3 ligands (ACE, CTP, CL), 2 pockets (best druggability 0.52). MolNFT v1 #113965 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 5AXV
- Type
- protein
- Length
- 247 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Polyhedrin
- UniProt
- P11041
- Ligands
- ACE, CTP, CL
- Pockets
- 2 · best druggability 0.52
Structure
x-ray diffraction · 1 distinct chain · 25% helix, 29% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Polyhedrin | protein | 247 | 25% helix, 29% strand | P11041 |
Ligands and binding sites
- ACE · Acetyl group · ligand · chains A
- CTP · Cytidine-5'-triphosphate · ligand · chains A
- CL · Chloride ion · ion · chains A
- EDO · 1,2-ethanediol · additive · 3 copies · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 158 | 0.52 | 0.79 | 23 | EDO |
| 2 | 50 | 0.25 | 0.74 | 12 | empty |
Modifications
Observed in the structure: 1 covalent (covalent ligand).
Compared structures
- 5AXV · Crystal Structure of Cypovirus Polyhedra R13K Mutant · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P11041
- Elsewhere: RCSB PDB 5AXV · PDBe 5AXV · UniProt P11041
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.